Iterum Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
FISHMAN COREY N. director, officer: President & ..
 Ordinary Shares 3,000 $13 $39,000
Purchase
AHRENS BRENTON KARL director
 Ordinary Shares 506,656 $13 $6,586,528
Purchase
MATTHEWS JUDITH M. officer: Chief Financial Officer
 Ordinary Shares 4,000 $13 $52,000
Purchase
CANAAN X L.P. director, 10 percent owner
 Ordinary Shares 506,656 $13 $6,586,528
Purchase
HUNT RONALD director
 Ordinary Shares 662,677 $13 $8,614,801
Purchase
HERON PATRICK J director
 Ordinary Shares 456,099 $13 $5,929,287
Purchase
MALIK SHAHZAD director
 Ordinary Shares 236,984 $13 $3,080,792
Purchase
DUNNE MICHAEL W. director
 Ordinary Shares 2,000 $13 $26,000
Purchase
HEALY JAMES 10 percent owner
 Ordinary Shares 500,000 $13 $6,500,000
Purchase
LATHI VIJAY K 10 percent owner
 Ordinary Shares 662,677 $13 $8,614,801
Purchase
SOFINNOVA VENTURE PARTNERS IX, L.P. 10 percent owner
 Ordinary Shares 500,000 $13 $6,500,000

Showing 100 to 111 of 111 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: